Salute e Benessere

Bavarian Nordic's Chikungunya Vaccine Receives Recommendation from U.S. CDC's…

Recommendation of first chikungunya vaccine for persons as young as 12 years old expands access for US travelers to regions with outbreak or elevated risk of chikungunya.COPENHAGEN, Denmark, April 16, 2025– Bavarian Nordic A/S (OMX: BAVA) announced today that the U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend the virus-like particle (VLP)-based, single-dose vaccine, VIMKUNYA™ (Chikungunya Vaccine,...
Nasdaq GlobeNewswire
16/04/2025

Basilea shareholders approve all proposals of the board of directors at the…

Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, reported that shareholders approved all proposals of the board of directors at today's annual general meeting (AGM) for the financial year 2024.At the AGM, the shareholders approved the annual report, the financial statements and the consolidated financial statements for...
Nasdaq GlobeNewswire
16/04/2025

Spineway : First-quarter 2025 revenue of €2.8 million

Press release Ecully, April 16, 2025 – 7.00 p.m. SPINEWAYFirst-quarter 2025 revenue of €2.8 millionIn thousands of euros 20252024Change as a %Q1 revenue 2,8283,070-8%Unaudited consolidated data Spineway, a specialist in innovative implants for the treatment of severe spine disorders, recorded revenue of €2.8 million in the first quarter of 2025, stable compared with the fourth quarter of 2024 and down 8% on the revenue for the first...
Nasdaq GlobeNewswire
16/04/2025

From Sci-Fi to Daily Life: Service Robots Step into Spotlight at 137th Canton…

Dreame Technology's AI-powered weeding robot makes backyard maintenance a hands-free affair. Equipped with 3D laser radar sensors and forward-facing cameras, this robot maps boundaries and avoids obstacles with high precision. Its floating blade system adapts to grass height and terrain, all while being ready to use right out of the box. Dreame Technology's AI-powered weeding robot makes backyard maintenance a hands-free affair. Equipped with 3D laser radar sensors and forward-facing cameras,...
PR Newswire
16/04/2025

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43…

Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, today reported financial results for the full year ended December 31, 2024. Full Year 2024 Financial HighlightsIncome Statement: FY 2024 performance was marked...
Nasdaq GlobeNewswire
16/04/2025

Valneva to Participate in Multiple Events at the 25th World Vaccine Congress…

Saint-Herblain (France), April 16, 2025– Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced its presence at the forthcoming 25th World Vaccine Congress, which will take place from April 21-24, 2025 at the Walter E. convention center in Washington, D.C. Under the leadership of the Company´s Chief Executive Officer, Thomas Lingelbach, a team of Valneva´s senior managers will participate in multiple events, including an important presentation on...
Nasdaq GlobeNewswire
16/04/2025

VIRGIL ABLOH FOUNDATION NAMES ATHI SELVENDRAN AS CHIEF CREATIVE OFFICER

Selvendran joins Dana Loatman, who was announced as the foundation's executive director in February 2025. As Chief Creative Officer of the foundation, Athi will be responsible for the preservation, cataloging, and launch of the Virgil Abloh Archives. He will also spearhead the creative design and implementation of global initiatives and impact programming like ABLOH AIR and co-lead brand collaborations and partnerships designed to increase exposure and opportunities for aspiring creatives…
PR Newswire
16/04/2025

US Radiotherapy Market worth US$2.49 billion by 2030 with 4.6% CAGR |…

Browse in-depth TOC on "US Radiotherapy Market" Browse in-depth TOC on "US Radiotherapy Market" 176 - Tables62 - Figures By Based on segment,Radiotherapy market is sub-segmented into systems/hardware, software, and services. In 2025, the system segment dominated the market with rising hardware sales driven by higher demand for innovative platforms across cancer care centers, favourable reimbursement policies, and the rising demand for non-invasive treatments. By...
PR Newswire
16/04/2025

Dental Chairs Market to Reach $820.84 Million By 2027 in the short run and…

Request Sample of the Report on Global Dental Chairs Market 2035 - https://www.alliedmarketresearch.com/request-sample/2658 Request Sample of the Report on Global Dental Chairs Market 2035 -https://www.alliedmarketresearch.com/request-sample/2658 Market Introduction A dental chair is a specialized medical device designed to position patients ergonomically during dental procedures while ensuring optimal access for practitioners. These chairs feature adjustable headrests, armrests,...
PR Newswire
16/04/2025

Nonwoven Fabrics Market to Reach $104.1 Billion, Globally, by 2033 at 6.0% CAGR…

Download Sample Pages of Research Overview: https://www.alliedmarketresearch.com/request-sample/A13919 Download Sample Pages of Research Overview:https://www.alliedmarketresearch.com/request-sample/A13919 Report Coverage & Details: The Polypropylene (PP) segment is expected to lead throughout the forecast period with a CAGR of 6.1%. By polymer type, the Polypropylene (PP) segment was the highest revenue contributor to the market growing with a CAGR of 6.1%. Increase in...
PR Newswire
16/04/2025

Clario Collaborates with AWS to Push New Boundaries in Clinical Data Analysis…

"Our collaboration with AWS represents a pivotal step forward in Clario's mission to streamline operations and deliver regulatory-grade data faster," said Jay Ferro, Chief Information, Technology and Product Officer at Clario. "By harnessing the power of AI, we're not only reducing operational burdens, but also improving data accuracy and quality to help our customers achieve greater compliance, and ultimately, improved patient outcomes." "Our collaboration with AWS…
PR Newswire
16/04/2025

Olon Receives 2025 CMO Excellence in Green Chemistry Award

Olon's innovative approach markedly reduces the reliance on solvents and toxic materials, while minimizing the use of excess building blocks by obviating the need for protecting groups. In comparison to conventional Solid Phase Peptide Synthesis (SPPS) methods, Olon's technology presents a more sustainable and efficient manufacturing process. "Our innovative approach to using recombinant DNA technology and chimeric protein expression for the sustainable production of therapeutic peptides...
Nasdaq GlobeNewswire
16/04/2025

Sabin Begins Marburg Vaccine Trial in U.S.

WASHINGTON, April16, 2025(GLOBE NEWSWIRE) -- The Sabin Vaccine Institute has launched a multi-site Phase 2 clinical trial in the U.S. for its Marburg vaccine candidate, administering doses to the first participants in Melbourne, Florida. This trial builds on ongoing Phase 2 testing in Kenya and Uganda, with initial findings from that research expected in the coming months.Sabin's vaccine development efforts, including clinical trials, are becoming increasingly critical as Marburg...
Nasdaq GlobeNewswire
16/04/2025

WHO and WEF Are Pushing AI in Global Healthcare -- What It Means for the Market

VANCOUVER, BC, April 16, 2025 /PRNewswire/ --Equity InsiderNews Commentary – The potential for artificial intelligence (AI) in healthcare is still unfolding, both for patients and providers. A recent report from Deloitte found that 71% of healthcare industry leaders expect improved profitability this year, and it comes with rising AI implementation in care. At a global level, the World Health Organization (WHO) recently launched a new AI collaboration center for healthcare through the Digital…
PR Newswire
16/04/2025

Transforming Lives with TAVI: A Milestone in Aortic Stenosis Treatment

Aortic stenosis is a serious heart valve condition characterized by narrowing and stiffening of the aortic valve, restricting blood flow from the heart to the body. This forces the heart to work harder, potentially leading to complications like heart failure. Symptoms include chest pain, shortness of breath, fatigue, and fainting, though some patients may remain asymptomatic until the disease progresses. Aortic stenosis is a serious heart valve condition characterized by narrowing and...
PR Newswire
16/04/2025

Global Health Innovators recognised with Abu Dhabi Global Health Week Innovation…

ADGHW Innovation Awards recipients include: ADGHW Innovation Awards recipients include: The award ceremony commenced with opening remarks byH.E. Dr.Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health –Abu Dhabi , who underscored the award's pivotal role in recognising excellence, fostering innovation, and accelerating progress across the healthcare sector. The event brought together senior government officials, healthcare leaders, and industry partners, including H.E...
PR Newswire
16/04/2025

AccuStem Sciences, Inc. Signs Agreement to Access Blood Samples from Lung Cancer…

LONDON and PHOENIX, April16, 2025(GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with or at risk of cancer, today announced a development agreement to access blood samples from the multi-institutional, prospective, randomized Rete Italiana di Screening Polmonare (RISP) clinical trial. This study is currently enrolling patients across a clinical network of 18 centers in Italy, and will further...
Nasdaq GlobeNewswire
16/04/2025

INTERIM ANALYSIS OF 2-LEVEL BAGUERA® C IDE STUDY MEETS THRESHOLD FOR…

Spineart has agreed with the U.S. FDA to submit the interim results from both IDE studies under the same PMA. Completion of this combined PMA submission remains scheduled for the end of August 2025, potentially enabling an earlier approval than had originally been anticipated. Spineart has agreed with the U.S. FDA to submit the interim results from both IDE studies under the same PMA. Completion of this combined PMA submission remains scheduled for the end ofAugust 2025, potentially enabling...
PR Newswire
16/04/2025

RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE…

RECORDATI: FDA GRANTS ISTURISA ® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING'S SYNDROME ISTURISA ®is a cortisol synthesis inhibitor that blocks the enzyme 11β-hydroxylase to help normalize hypercortisolemia in Cushing's syndrome, a rare endocrine condition that can have significant impact on patients and their familiesThe expanded indication is supported by an extensive clinical development program Milan,...
Nasdaq GlobeNewswire
16/04/2025

Healthera secures £2m strategic investment to accelerate digital pharmacy…

With a sustainable foundation set in 2024, the company - which already provides technology for over 1,700 UK pharmacies and over a million patients - is now poised for significant expansion across the UK and North America and into new revenue verticals, including private medicine prescribing and the end-to-end management of clinical services. With a sustainable foundation set in 2024, the company - which already provides technology for over 1,700 UK pharmacies and over a million patients - is...
PR Newswire
16/04/2025

Chime Biologics Partners Polpharma Biologics to Advance Global Biosimilar…

Meeting Global Supply Needs Meeting Global Supply Needs Polpharma Biologics, a major player in the global biosimilar market and the largest biotechnology company inPoland, brings a robust pipeline that includes multiple early-stage and late-stage biosimilars, along with two FDA/EMA-approved biosimilar products. With an extensive track record in delivering biosimilars for global markets, Chime Biologics is well-positioned to meet the growing global demand for biosimilars. Through...
PR Newswire
16/04/2025

Conditional Issuance of Shares

INSIDE INFORMATION REGULATED INFORMATIONConditional Issuance of Shares Mont-Saint-Guibert, Belgium – April 16, 2025, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), today announced a conditional issuance of up to 5 million ordinary shares under its existing at-the-market equity offering programs (the “ ATM ”). This brings the aggregate number of ordinary shares that can be sold and issued under the Company's ATM to 5,662,694 (the “...
Nasdaq GlobeNewswire
16/04/2025

LUMA Vision Receives FDA Clearance for VERAFEYE 2D/4D Cardiac Visualization…

The VERAFEYE system combines state-of-the-art imaging technology with advanced digital maneuverability, enabling clinicians to capture highly detailed, four-dimensional images that update in real time. With imaging depths up to 120 mm away from the catheter, it allows for dynamic high-resolution navigation and visualization of the heart, crucial to performing today's advanced electrophysiology and structural heart procedures with a wide variety of technologies. Traditional imaging catheters…
PR Newswire
16/04/2025

Basilea reports presentation of new data for fosmanogepix, isavuconazole…

Allschwil, Switzerland, April 16, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today scientific presentations on Basilea's clinical-stage novel antifungal fosmanogepix given at ESCMID Global 2025, the annual meeting of the European Society of Clinical Microbiology and Infectious Diseases, which took place from April 11 to 15, 2025 in Vienna…
Nasdaq GlobeNewswire
16/04/2025
Altri  Comunicati